Mycobacterium chelonae infection after fractionated carbon dioxide facial resurfacing (Presenting as an Atypical Acneiform Eruption): Case report and literature review

Dermatologic Surgery

Volumn 36, Issue 9, 2010, Pages 1473-1481

  Palm, Melanie D ^a   Butterwick, Kimberly J ^a   Goldman, Mitchel P ^a  

^a Dermatology & Cosmetic Laser Associates of La Jolla   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BENZOYL PEROXIDE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DAPSONE; DEXAMETHASONE; DOXYCYCLINE; FLUCONAZOLE; HYDROCORTISONE; KETOCONAZOLE; LINEZOLID; METHYLPREDNISOLONE; METRONIDAZOLE; MINOCYCLINE; TRIAMCINOLONE; VALACICLOVIR;

ACNE; ADULT; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CARBON DIOXIDE LASER; CASE REPORT; ERBIUM YAG LASER; ESTHETICS; FACE ERYTHEMA; FACE INJURY; FEMALE; HUMAN; MYCOBACTERIUM CHELONEI; PHOTOAGING; PRIORITY JOURNAL; SKIN DEFECT; WRINKLE;

ACNEIFORM ERUPTIONS; FEMALE; HUMANS; LASERS, GAS; MIDDLE AGED; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; PLASMA SKIN REGENERATION;

EID: 77956282312     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01663.x     Document Type: Article

References (56)

1. Manuskiatti W, Fitzpatrick RF, Goldman MP, et al. Prophylactic antibiotics in patients undergoing laser resurfacing of the skin. J Am Acad Dermatol 1999 40 : 77 84.
2. 2 laser. Dermatol Surg 2002 28 : 768 771.
3. Waibel J, Beer K, Narurkar V, Alster TS. A comparison of several fractional ablative resurfacing laser devices: preliminary technological and clinical review. J Drugs Dermatol 2009 8 : 481 485.
4. 2 laser, a review of 373 treatments. Dermatol Surg, in press.
5. Pinner M. Atypical acid-fast microorganisms. Am Rev Tuberc 1935 32 : 424 425.
6. Driscoll MS, Tyring SK. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol 1997 36 : 495 496.
7. Ena P, Zanetti S, Sechi LA. Mycobacterium chelonae I infection mimicking acne conglobata in an immunocompetent host. Clin Exp Dermatol 2004 29 : 423 436.
8. Fabrioni C, Buggiani G, Lotti T. Therapy of environmental mycobacterial infections. Dermatol Ther 2008 21 : 162 166.
9. Jogi R, Tyring SK. Therapy of nontuberculous mycobacterial infections. Dermatol Ther 2004 17 : 491 498.
10. Sniezek PJ, Graham BS, Byers Busch H, et al. Rapidly growing mycobacterial infections after pedicures. Arch Dermatol 2003 139 : 629 634.
11. 2 & Er:YAG lasers. Dermatol Surg 1999 25 : 160 163.
12. Bowes LE, Alster TS. Treatment of facial scarring and ulceration resulting from acne excoriée with 585-nm pulsed dye laser irradiation and cognitive psychotherapy. Dermatol Surg 2004 30 : 934 938.
13. Patel N, Clement M. Selective nonablative treatment of acne scarring with 585 nm flashlamp pulsed dye laser. Dermatol Surg 2002 28 : 942 945.
14. Bhardwaj SS, Rohrer TE, Arndt K. Lasers and light therapy for acne vulgaris. Semin Cutan Med Surg 2005 24 : 107 112.
15. Harto A, García-Morales I, Beldar P, et al. Pulsed dye laser treatment of acne: study of clinical efficacy and mechanism of action. Actas Dermosifiliogr 2007 98 : 415 419.
16. Herrero JB, Borbujo C, Roman MT, et al. Cutaneous infection caused by Mycobacterium chelonae: presentation of 3 cases with multiple lesions. Rev Clin Exp 1996 196 : 606 609.
17. Dessy LA, Mazzocchi M, Fioramonti P, et al. Conservative management of local Mycobacterium chelonae infection after combined liposuction and lipofilling. Aesth Plast Surg 2006 30 : 717 722.
18. Huang TS, Lee SSJ, Hsueh PR, et al. Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002. J Formos Med Assoc 2008 107 : 281 287.
19. Wallace RJ Jr., Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993 119 : 482 486.
20. Bordet AL, Machet L, De Muret A, et al. Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin. Ann Dermatol Venereol 1997 124 : 251 253.
21. Demitsu T, Nagato H, Inoue T. Cutaneous Mycobacterium chelonae infection with bilateral sporotrichoid involvement. Int J Dermatol 2001 40 : 597 599.
22. Drabick JJ, Duffy PE, Samlaska CP, Scherbenske JM. Disseminated Mycobacterium chelonae subspecies chelonae infection with cutaneous and osseous manifestations. Arch Dermatol 1990 126 : 1064 1067.
23. Safranek TJ, Jarvis WR, Carson LA, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987 317 : 197 201.
24. Hoetzenecker W, Ulmer A, Klingel K, et al. Dissemination of a localized cutaneous infection with Mycobacterium chelonae under immunosuppressive treatment. Arch Dermatol 2007 143 : 951 952.
25. Kelley LC, Deering KC, Kaye ET. Cutaneous Mycobacterium chelonei presenting in an immunocompetent host: case report and review of the literature. Cutis 1995 56 : 293 295.
26. Palwade PK, Dhurat RS, Tendolkar UM, et al. Chronic cutaneous disease caused by the rapid growers Mycobacterium fortuitum and chelonae. Br J Dermatol 2006 154 : 774 775.
27. Sran PK, Kansupada K, Whitcup SM. Mycobacterium chelonae infection mimicking cutaneous vasculitis: case report. Clin Infect Dis 1996 23 : 1189 1191.
28. Wallace RJ Jr., Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992 166 : 405 412.
29. Saha M, Azadian BS, Ion L, et al. Mycobacterium chelonae infection complicating cosmetic facial surgery. Br J Dermatol 2006 154 : 1097 1099.
30. Meyers H, Brown-Elliott BA, Moore D, et al. An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis 2002 34 : 1500 1507.
31. Knackmuhs G, Gerwel M, Patterson C, et al. Mycobacterium chelonae infections associated with face lifts - New Jersey, 2002-2003. MMWR Morb Mortal Wkly Rep 2004 53 : 192 194.
32. Latorre-Gonzalez G, Garcia-Garcia M, Martinez-Colubi M, et al. Disseminated cutaneous infection by Mycobacterium chelonae after botulinic toxin injection in an immunosuppressed patient. Med Clin 2005 125 : 439.
33. Hay RJ. Mycobacterium chelonae - a growing problem in soft tissue infection. Curr Opin Infect Dis 2009 22 : 99 101.
34. Vess RW, Anderson RL, Carr JH, et al. The colonization of solid PVC surfaces and the acquisition of resistance to germicides by water micro-organisms. J Appl Bacteriol 1993 74 : 215 221.
35. 2 laser resurfacing: four cases. Lasers Surg Med 2009 41 : 179 184.
36. Alster TS, Lupton JR. Treatment of complications of laser skin resurfacing. Arch Facial Plast Surg 2000 2 : 279 284.
37. Sriprachya-Anunt S, Fitzpatrick RF, Goldman MP, et al. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg 1997 23 : 527 535.
38. Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007 57 : 413 420.
39. Bañuls J, Ramón R, Pascual E, et al. Mycobacterium chelonae infection resistant to clarithromycin in a patient with dermatomyositis. Br J Dermatol 2000 143 : 1345.
40. Tartaglione T. Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. Clin Therapeut 1997 19 : 626 638.
41. Vemulapalli RK, Cantey JR, Steed LL, et al. Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infections: case report and literature review. J Infect 2001 43 : 163 168.
42. Wallace RJ Jr., Brown-Elliott BA, Ward SC, et al. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001 45 : 764 767.
43. Rodriguez JC, Garcia-Pachon E, Flores E, et al. Generation of resistant mutants of Mycobacterium chelonae and Mycobacterium fortuitum after exposure to subinhibitory concentrations of clarithromycin and moxifloxacin. J Chemother 2007 19 : 599 601.
44. Franck N, Cabié A, Billette B, et al. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. J Am Acad Dermatol 1993 28 : 1019 1021.
45. Gevaudan MJ, Bollet C, de Micco P. Evaluation of the extra- and intracellular activity of clarithromycin against Mycobacterium chelonae. Pathol Biol 1994 42 : 412 418.
46. Peres E, Khaled Y, Krijanovski OI, et al. Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline. Transpl Infect Dis 2008 11 : 57 63.
47. Brown-Elliott BA, Wallace RJ Jr., Blinkhorn R, et al. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 2001 33 : 1433 1434.
48. Cavusoglu C, Soyler I, Akinci P. Activities of linezolid against nontuberculous mycobacteria. New Microbiol 2007 30 : 411 414.
49. Tebas P, Sultan FF, Wallace RJ, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 1995 20 : 443 444.
50. Wallace RJ Jr., Meier A, Brown BA, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996 40 : 1676 1681.
51. Kyle SD, Porter WM. Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid. Br J Dermatol 2004 151 : 1101.
52. Kullavanijaya P, Rattana-Apiromyakij N, Sukonthapirom-Napattalung P, et al. Disseminated Mycobacterium chelonae cutaneous infection: recalcitrant to combined antibiotic therapy. J Dermatol 2003 30 : 485 491.
53. Levine N, Rothschild JG. Treatment of Mycobacterium chelonae infection with controlled localized heating. J Am Acad Dermatol 1991 24 : 867 870.
54. Yoshida Y, Urabe K, Rurue M, Nakayama J. A case of cutaneous Mycobacterium chelonae infection successfully treated with a combination of minocycline hydrochloride and thermotherapy. J Dermatol 2004 31 : 151 153.
55. Walia S, Alster TS. Cutaneous CO2 laser resurfacing infection rate with and without prophylactic antibiotics. Dermatol Surg 1999 25 : 857 861.
56. Gaspar Z, Vincuillo C, Elliott T. Antibiotic prophylaxis for full-face laser resurfacing: is it necessary. Arch Dermatol 2001 137 : 313 315.